
- 冲击高端领域 捷尼赛思正式进入中国市场 车质网
- METHYLENEBIS ACRYLAMIDE, 2% SO
- Echelon_价格厂家供应商_默瑞(上海)生物科技有限公司 ...
- Synaptic Systems代理,Synaptic Systems授权代理商,Synaptic...
- Echelon 是脂质研究和脂质与蛋白质相互作用研究领域的领路者仪器资料...
- allelebiotech【allele biotech】【中国试剂网】 allelebiotech...
- 人纤维肉瘤细胞
- 供应DMOG (dimethyloxalylglycine)_价格厂家供应商_北京 ...
- echelon公司报价 echelon|产品详情|
- 小鼠三磷酸磷脂酰肌醇(PIP3)elisa检测试剂盒
- Echelon Biosciences Incorporated 上等代理|产品详情|上海蚂蚁淘...
- 日本Fujirebio公司将提供价格低廉的AIDS抗体试验《国外医学...

N-terminal His-tagged, recombinant human SHIP2 (truncated form containing SH2 domain and inositol 5-phophatase catalytic domain)
Storage: Store product > -70 ºC. Enzyme is stable for at least 6 months at -70 ºC as undiluted stockSpecificity: SHIP2 selectively removes the phosphate from the 5’ position of the inositol ring of PtdIns(3,4,5)P3Molecular Weight: 103 kDaSpecific Activity: request Certificate of Analysis (COA)
This His-tagged, recombinant human SHIP2 (truncated form containing SH2 domain and inositol 5-phophatase catalytic domain) is tested for activity against PIP3 and is purified from E.coli using Ni-NTA column chromatography.
SH2-containing 5`-inositol phosphatase 2 (SHIP2) is a lipid phosphatase which converts PI(3,4,5)P3 to PI(3,4)P2. This negative regulation of insulin signaling has a fundamental impact on insulin resistance. SHIP2 down-regulates insulin signaling and is present at higher levels in diabetes and obesity. Abnormalities in SHIP function are increasingly linked to disease, in particular in the role of SHIP as a negative regulator of cytokine and immune receptor signaling.
Publications
1. Drees, B. E., A. Weipert, et al. (2003). “Competitive fluorescence polarization assays for the detection of phosphoinositide kinase and phosphatase activity.” Comb Chem High Throughput Screen 6(4): 321-30.2. Brooks, R., G. M. Fuhler, et al. (2010). “SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells.” J Immunol 184(7): 3582-9.3. Fuhler, G. M. B., R, Toms, Iyer, Geno (2012). “Therapeutic potential of SHIP1 and SHIP2 inhibition in cancer cells.” Molecular Medicine 18: 65-75.4. Agollah, G. D., et al. (2014). “Evidence for SH2 Domain-Containing 5′-Inositol Phosphatase-2 (SHIP2) Contributing to a Lymphatic Dysfunction.” PLoS ONE 9(11): e112548.5. Proctor, A., et al. (2017). “Chemical fixation to arrest phospholipid signaling for chemical cytometry.” Journal of Chromatography A 1523(10): 97-106.6. Willett, R., et al. (2017). “TFEB regulates lysosomal positioning by modulating TMEM55B expression and JIP4 recruitment to lysosomes.” Nature Communications 8(1): 1580.
Categories | Antibodies & Proteins |
---|---|
Filter | Enzyme, Phosphatase, SHIP |